These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8913489)
1. Antimicrobial susceptibility pattern of Corynebacterium striatum. Martínez-Martínez L; Pascual A; Bernard K; Suárez AI Antimicrob Agents Chemother; 1996 Nov; 40(11):2671-2. PubMed ID: 8913489 [TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics. Philippon A; Bimet F Eur J Clin Microbiol Infect Dis; 1990 Dec; 9(12):892-5. PubMed ID: 2073900 [TBL] [Abstract][Full Text] [Related]
3. The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs. Prescott JF J Vet Pharmacol Ther; 1981 Mar; 4(1):27-31. PubMed ID: 7349320 [TBL] [Abstract][Full Text] [Related]
4. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Fernández-Roblas R; Prieto S; Santamaría M; Ponte C; Soriano F Antimicrob Agents Chemother; 1987 May; 31(5):821-2. PubMed ID: 3606082 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium. Traub WH; Geipel U; Leonhard B; Bauer D Chemotherapy; 1998; 44(4):230-7. PubMed ID: 9681199 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748 [TBL] [Abstract][Full Text] [Related]
7. Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. Koeth LM; King A; Knight H; May J; Miller LA; Phillips I; Poupard JA J Antimicrob Chemother; 2000 Sep; 46(3):369-76. PubMed ID: 10980162 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Corynebacterium group D2. Santamaría M; Ponte C; Wilhelmi I; Soriano F Antimicrob Agents Chemother; 1985 Dec; 28(6):845-6. PubMed ID: 4083869 [TBL] [Abstract][Full Text] [Related]
9. Teicoplanin combined with various antibiotics and human blood against a multiple-drug-resistant strain of Staphylococcus aureus. Traub WH; Spohr M; Bauer D Chemotherapy; 1991; 37(3):186-95. PubMed ID: 1832374 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen Lefèvre CR; Pelletier R; Le Monnier A; Corvec S; Bille E; Potron A; Fihman V; Farfour E; Amara M; Degand N; Barraud O; Cattoir V; For The Gmc Study Group J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734955 [No Abstract] [Full Text] [Related]
11. In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). Muñoz-Bellido JL; Muñoz-Criado S; García-Rodríguez JA J Antimicrob Chemother; 1996 May; 37(5):1005-9. PubMed ID: 8737151 [TBL] [Abstract][Full Text] [Related]
12. Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Cohen MA; Huband MD Diagn Microbiol Infect Dis; 1999 Jan; 33(1):43-6. PubMed ID: 9990475 [TBL] [Abstract][Full Text] [Related]
13. Comparison between disk diffusion and agar dilution methods to determine in vitro susceptibility of Corynebacterium spp. clinical isolates and update of their susceptibility. Barberis CM; Sandoval E; Rodriguez CH; Ramírez MS; Famiglietti A; Almuzara M; Vay C J Glob Antimicrob Resist; 2018 Sep; 14():246-252. PubMed ID: 29782954 [TBL] [Abstract][Full Text] [Related]
14. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Bernard EM; Edwards FF; Kiehn TE; Brown ST; Armstrong D Antimicrob Agents Chemother; 1993 Nov; 37(11):2323-6. PubMed ID: 8285613 [TBL] [Abstract][Full Text] [Related]
16. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Weiss K; Laverdière M; Rivest R Antimicrob Agents Chemother; 1996 Apr; 40(4):930-3. PubMed ID: 8849254 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Soriano F; Zapardiel J; Nieto E Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Mycobacterium avium complex to antibacterial agents. Davis CE; Carpenter JL; Trevino S; Koch J; Ognibene AJ Diagn Microbiol Infect Dis; 1987 Nov; 8(3):149-55. PubMed ID: 3440370 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials. Chudnicka A; Kozioł-Montewka M Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020 [TBL] [Abstract][Full Text] [Related]
20. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples. Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]